Platform now provides unique insights into market dynamics and competitive strategiesSOMERSET, N.J., Dec. 10, 2025 /PRNewswire/ -- VCTI, a technology and…
Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 data for allogeneic…